Daily Archives: July 14, 2025

The Latest FDA Approved Neuromodulator Letybo

Letybo (letibotulinumtoxinA) is a newer botulinum toxin type A formulation developed by Hugel, a South Korean biopharmaceutical company. It joins a growing list of botulinum neurotoxin serotype A (BoNT-A) products used in aesthetic and therapeutic medicine. The primary competitors of … Continue reading

Posted in Uncategorized | Leave a comment